GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,560,000 | +0.9% | 138,400 | +1.2% | 0.77% | 0.0% |
| Q2 2018 | $5,510,000 | +2.3% | 136,700 | -0.8% | 0.77% | -2.4% |
| Q1 2018 | $5,384,000 | +8.3% | 137,800 | -1.7% | 0.79% | +8.6% |
| Q4 2017 | $4,973,000 | -19.6% | 140,200 | -7.9% | 0.72% | -22.6% |
| Q3 2017 | $6,183,000 | -7.6% | 152,300 | -1.8% | 0.94% | -10.8% |
| Q2 2017 | $6,688,000 | -1.3% | 155,100 | -3.5% | 1.05% | +1.4% |
| Q1 2017 | $6,779,000 | +9.2% | 160,800 | -0.2% | 1.04% | +12.5% |
| Q4 2016 | $6,208,000 | +665.5% | 161,200 | +757.4% | 0.92% | +614.0% |
| Q3 2016 | $811,000 | -0.5% | 18,800 | 0.0% | 0.13% | -6.5% |
| Q2 2016 | $815,000 | +7.0% | 18,800 | 0.0% | 0.14% | +5.3% |
| Q1 2016 | $762,000 | +0.4% | 18,800 | 0.0% | 0.13% | -3.0% |
| Q4 2015 | $759,000 | -75.4% | 18,800 | -76.6% | 0.14% | -69.7% |
| Q3 2015 | $3,091,000 | -4.6% | 80,400 | +3.3% | 0.44% | +16.2% |
| Q2 2015 | $3,240,000 | -77.5% | 77,800 | -75.1% | 0.38% | -64.7% |
| Q1 2015 | $14,404,000 | +8.0% | 312,100 | 0.0% | 1.08% | +7.1% |
| Q4 2014 | $13,339,000 | – | 312,100 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |